SEC fundamentals
Braveheart Bio, Inc. (BRVE)
as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗
Quarter-end price
Derived from SEC filings · not a live quote · USD per share
Each price is as of its date, from the filings that reported it, and is never adjusted; the full series with each price's sources is in the docs.
In its 10-Q for the period ended Sep 30, 2026, Braveheart Bio, Inc. reported net income of -$26.5M and total assets of $514.5M. Every figure below is taken directly from Braveheart Bio, Inc.'s SEC filings: each links to the source document on EDGAR.
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 10-Q | Nov 10, 2026 | on EDGAR ↗ |
| 8-K | Nov 10, 2026 | on EDGAR ↗ |
| 8-K | Nov 6, 2026 | on EDGAR ↗ |
| 8-K | Sep 8, 2026 | on EDGAR ↗ |
| 10-Q | Sep 8, 2026 | on EDGAR ↗ |
| 8-K | Aug 7, 2026 | on EDGAR ↗ |
| S-1 | Jul 15, 2026 | on EDGAR ↗ |
Balance Sheet
as of Sep 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Sep 30, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Sep 30, 2026
| EPS (diluted) | $-0.51 | Earnings | source ↗ |
| EPS (basic) | $-0.51 | Earnings | source ↗ |
| Shares Outstanding | 89.9M | Entity | source ↗ |
| Cash from Operations | -$24.4M | Net | source ↗ |
| Cash from Financing | $405.3M | Net | source ↗ |
| Cash from Investing | -$382.4M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 11
- Sells
- 0
- Net shares
- +6.9M
Restatement history
Point-in-timeNo material restatements detected across 0 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches BRVE’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Starter extends the ratios to 20 quarters and adds the Piotroski F-score and accruals quality score; Analyst extends the trajectory to up to 20 years. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Starter removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BRVE
MCP tool:
get_sec_fundamentals ticker=BRVE - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BRVE/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=BRVE as_of=YYYY-MM-DD - Quarter-end prices derived from SEC filings, with their sources and splits
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/prices/BRVE/history?frequency=quarter
MCP tool:
get_sec_price_history ticker=BRVE frequency=quarter - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/BRVE/history
MCP tool:
get_fundamentals_history ticker=BRVE - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/BRVE
MCP tool:
get_financial_health ticker=BRVE
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.